These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12947862)

  • 1. C0/C2 cyclosporine levels monitoring in renal transplantation.
    Santana A; Guerra J; Milhomens C; Neves F; Prata MM
    Transplant Proc; 2003 May; 35(3):1072-3. PubMed ID: 12947862
    [No Abstract]   [Full Text] [Related]  

  • 2. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice.
    Vathsala A; Lu YM
    Transplant Proc; 2001; 33(7-8):3137-9. PubMed ID: 11750348
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-center study utilizing C(2) level as monitoring tool in de novo renal transplant recipients treated with Neoral.
    Keshavamurthy M; Al Ahmadi I; Mohammed Raza S; Baynton R; Al Meshari K; Al Shaibani K
    Transplant Proc; 2001; 33(7-8):3112-4. PubMed ID: 11750338
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of cyclosporine therapeutic monitoring with C2 concentrations in stable renal allograft recipients.
    Díaz JM; Sainz Z; Guirado LL; Montañés R; Picazo M; García-Camín R; Alcaraz A; Solà R
    Transplant Proc; 2003 Aug; 35(5):1783-4. PubMed ID: 12962794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of C0 and C2 cyclosporine monitoring in long-term renal transplant recipients.
    Marcén R; Pascual J; Tato A; Villafruela JJ; Teruel JL; Rivera ME; Tenorio M; Fernández M; Burgos FJ; Ortuño J
    Transplant Proc; 2003 Aug; 35(5):1780-2. PubMed ID: 12962793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients.
    Citterio F; Scatà MC; Borzi MT; Pozzetto U; Castagneto M
    Transplant Proc; 2001; 33(7-8):3133-6. PubMed ID: 11750347
    [No Abstract]   [Full Text] [Related]  

  • 7. Area under the curve of Neoral and chronic use of mycophenolate mofetil.
    Rial M; Guardia O; Greco G; Argento J; Casadei D
    Transplant Proc; 1998 Jun; 30(4):1195-6. PubMed ID: 9636484
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine Neoral profiling in Japanese renal transplant recipients.
    Aikawa A; Arai K; Tajima E; Kawamura T; Ogiwara H; Sakai K; Mizuiri S; Ohara T; Hasegawa A; Kosugi T; Kusano A; Matsuo K; Obayashi M; Kurokawa M
    Transplant Proc; 2001; 33(7-8):3142-5. PubMed ID: 11750350
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic study of mycophenolate mofetil in Asian renal transplant recipients.
    Yeung S; Tong KL; Tsang WK; Chan HW; Chan AY
    Transplant Proc; 2000 Nov; 32(7):1753-4. PubMed ID: 11119920
    [No Abstract]   [Full Text] [Related]  

  • 10. Greater variability of dose-corrected cyclosporine C2 concentrations in renal recipients with acute rejection.
    Chueh SC; Liao CH; Lai MK
    Transplant Proc; 2003 Feb; 35(1):234-5. PubMed ID: 12591378
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant.
    Yang WC; Chen YF; King KL; Wu TH; Chen Hsu RY ; Tang JJ; Loong CC; Chou MH; Lin MF; Lui WY
    Transplant Proc; 2000 Nov; 32(7):1685-7. PubMed ID: 11119892
    [No Abstract]   [Full Text] [Related]  

  • 12. Population pharmacokinetics of cyclosporine in kidney transplant patients.
    Porta B; Pérez-Ruixo JJ; Górriz JL; Crespo JF; Sancho A; Pallardó LM; Jiménez NV
    Transplant Proc; 1999 Sep; 31(6):2246-7. PubMed ID: 10500561
    [No Abstract]   [Full Text] [Related]  

  • 13. Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection.
    Balshaw R; Machnicki G; Carreño CA; Toselli L; Otero A; Keown PA
    Transplant Proc; 2005 Mar; 37(2):871-4. PubMed ID: 15848560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical and clinical evaluation of the EMIT mycophenolic acid immunoassay in kidney transplantation.
    Mourad M; Chaib-Eddour D; Malaise J; König J; Squifflet JP; Wallemacq PE
    Transplant Proc; 2000 Mar; 32(2):404-6. PubMed ID: 10715456
    [No Abstract]   [Full Text] [Related]  

  • 15. Neoral drug monitoring in stable kidney allotransplant recipients: C(0) versus C(2).
    Lukaschek J; Hofmann J; Aerne D; Ambühl P; Kistler T; Knoflach A; Pei P; Binswanger U
    Transplant Proc; 2001; 33(7-8):3104-5. PubMed ID: 11750334
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoral C2 monitoring in solid organ transplantation.
    Levy GA
    Transplant Proc; 2004 Mar; 36(2 Suppl):392S-395S. PubMed ID: 15041373
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of two-point AUC(0-4) monitoring in maintenance renal transplant patients.
    Uchida K; Tominaga Y; Haba T; Katayama A; Sato T; Matsuoka S; Goto N; Kimata T; Takeda A; Morozumi K; Takagi H; Kobayashi T; Yokoyama I; Nakao A
    Transplant Proc; 2001; 33(7-8):3128-30. PubMed ID: 11750345
    [No Abstract]   [Full Text] [Related]  

  • 18. High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment.
    Engelbertink R; Smak Gregoor P; Hesse C; IJzermans J; Weimar W; van Gelder T
    Transplant Proc; 2002 Nov; 34(7):2983-4. PubMed ID: 12431677
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoral (cyclosporine) C2 monitoring in renal transplant recipients: a single-center experience in Asia.
    Wong HS; Morad Z
    Transplant Proc; 2003 Feb; 35(1):230-1. PubMed ID: 12591376
    [No Abstract]   [Full Text] [Related]  

  • 20. C2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipients.
    Weber LT; Shipkova M; Armstrong VW; Mehls O; Oellerich M; Tönshoff B;
    Transplant Proc; 2003 Sep; 35(6):2128-30. PubMed ID: 14529863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.